<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6731</number>
    <updateDate>2023-01-11T13:43:00Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:43:00Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2020-05-05</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 166, Number 84 (Tuesday, May 5, 2020)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. STAUBER:H.R. 6731.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8.[Page H1980]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-05-05T14:33:25Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2020-05-05</actionDate>
        <text>Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-05-05</actionDate>
        <text>Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hlvc00</systemCode>
            <name>Select Subcommittee on the Coronavirus Pandemic</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-05-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-05-05</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001212</bioguideId>
        <fullName>Rep. Stauber, Pete [R-MN-8]</fullName>
        <firstName>Pete</firstName>
        <lastName>Stauber</lastName>
        <party>R</party>
        <state>MN</state>
        <district>8</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000559</bioguideId>
        <fullName>Rep. Garamendi, John [D-CA-3]</fullName>
        <firstName>John</firstName>
        <lastName>Garamendi</lastName>
        <party>D</party>
        <state>CA</state>
        <district>3</district>
        <sponsorshipDate>2020-05-05</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000563</bioguideId>
        <fullName>Rep. Gibbs, Bob [R-OH-7]</fullName>
        <firstName>Bob</firstName>
        <lastName>Gibbs</lastName>
        <party>R</party>
        <state>OH</state>
        <district>7</district>
        <sponsorshipDate>2020-05-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001088</bioguideId>
        <fullName>Rep. Hagedorn, Jim [R-MN-1]</fullName>
        <firstName>Jim</firstName>
        <lastName>Hagedorn</lastName>
        <party>R</party>
        <state>MN</state>
        <district>1</district>
        <sponsorshipDate>2020-05-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Government Operations and Politics</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Public contracts and procurement</name>
        </item>
        <item>
          <name>Trade agreements and negotiations</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Government Operations and Politics</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-05-05</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2020-05-19T18:53:19Z</updateDate>
        <text><![CDATA[ <p><b>Securing America's Pharmaceutical Supply Chain Act</b></p> <p>This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.</p> <p>This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.</p> <p>The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.</p>]]></text>
      </summary>
    </summaries>
    <title>Securing America’s Pharmaceutical Supply Chain Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Securing America’s Pharmaceutical Supply Chain Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Securing America’s Pharmaceutical Supply Chain Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2020-05-05T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr6731ih/xml/BILLS-116hr6731ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-05-05</actionDate>
      <text>Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
